While primary SARS-CoV-2 infection will continue to occur as calcitriol targets the post-entry steps of infection, the upregulation of LL-37 via the VDR pathway will subsequently prevent secondary SARS-CoV-2 infection among cells, resulting in an overall reduction of virus titre. The gene discussed is VDR; the disease is infection.